Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir and Vaccination to Prevent de Novo Hepatitis B in Liver Transplant
NCT01146808Phase 2Completed
- Sponsor
- Columbia University
- Start
- Mar 2006
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adefovir dipivoxil in hepatitis B (HBV), sponsored by Columbia University. Primary endpoint: Development of de Novo Hepatitis B Infection After Transplant With a Core Antibody Positive Liver at 2 years. Started Mar 2006; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01146808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146808.